Mark E Gentry, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 112 Hospital Lane, Suite 200, Danville, IN 46122 Phone: 317-745-3366 Fax: 317-745-8528 |
Clark E Boccone, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 112 Hospital Ln, Suite 200, Danville, IN 46122 Phone: 317-745-3366 Fax: 317-745-8528 |
Dr. Rukeme Ake-uzoigwe, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 112 Hospital Ln Ste 200, Danville, IN 46122 Phone: 317-745-3366 Fax: 317-745-8528 |
Barbara A Koewler, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 112 Hospital Lane, Suite 200, Danville, IN 46122 Phone: 317-745-3366 Fax: 317-745-8528 |
Ian Johnston, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 112 Hospital Ln Ste 302, Danville, IN 46122 Phone: 317-272-7510 Fax: 317-272-7514 |
News Archive
Over 6,500 new cases of bladder cancer in Europe are caused by exposure to chemicals called trihalomethanes (THM) found in drinking water. This number adds up to almost 5% of all bladder cancers in the continent. The study, published in the journal Environmental Health Perspectives in January 2020, is a pioneering attempt to establish the levels of these chemicals in tap water supplied in 26 countries in the European Union.
New research from Japan brings hope of a new treatment for asthma patients resistant to corticosteroids. In a study published today in the journal Nature Communications, researchers from the RIKEN Center for Integrative Medical Sciences and Keio University in Japan report that a type of lymphocytes called natural helper ells plays a critical role in corticosteroid resistance and demonstrate that the anti-psychotic drug Pimozide can be used to overcome resistance to steroids in severe asthma patients.
The Weizmann Institute of Science in Rehovot, Israel today announced major scientific instrument purchases from Bruker (NASDAQ: BRKR), including a novel Aeon™ 1GHz nuclear magnetic resonance (NMR) system for expanding frontiers in structural biology and intrinsically disordered protein (IDPs) research. Furthermore, the Weizmann Institute is adding an Aeon 600 MHz NMR, a 263 GHz dynamic nuclear polarization (DNP)-NMR system, and a Biospec® 15 Tesla system for preclinical ultra-high field magnetic resonance imaging (MRI). Various NMR and electron paramagnetic resonance (EPR) instrument upgrades round out this major acquisition, instantly propelling the Weizmann Institute to the frontiers of modern magnetic resonance research infrastructure.
Fresenius Medical Care AG & Co. KGaA, the world's largest provider of dialysis products and services, is expanding its dialysis services business in the Russian Federation. The company announced today that it has signed an agreement to acquire KNC (KRAEVOY NEFROLOGICHESKIY CENTR), a private operator of dialysis clinics in Russia's Krasnodar region. The acquired operations will add approximately $25 million in annual revenue and are expected to be accretive to earnings in the first year after closing of the transaction.
› Verified 4 days ago